The discovery has implications for tailored treatments and the development of new drugs.
Associate Professor Guozhen Liu has been recognised for breakthroughs in individualised treatment for autoimmune diseases and cancer.
Breakthrough cellular genomics technology has allowed Garvan and UNSW Sydney researchers to reveal genetic mutations causing rogue behaviour in the cells at the root of autoimmune disease.
